UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunotherapy-Induced Airway Disease: A New Pattern of Lung Toxicity of Immune Checkpoint Inhibitors

Respiration, 2020-02, Vol.99 (2), p.181-186

2020

Volltextzugriff (PDF)

Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma

International journal of molecular sciences, 2023-03, Vol.24 (5), p.4520

2023

Volltextzugriff (PDF)

Gender profile of principal investigators in a large academic clinical trials group

Frontiers in surgery, 2022-07, Vol.9, p.962120-962120

2022

Volltextzugriff (PDF)

Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48Leu- and FGFR4 p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized Oncology

International journal of molecular sciences, 2020-10, Vol.21 (21), p.8021

2020

Volltextzugriff (PDF)

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

Journal for immunotherapy of cancer, 2021-02, Vol.9 (2), p.e001701

2021

Volltextzugriff (PDF)

Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient

Journal for immunotherapy of cancer, 2019-12, Vol.7 (1), p.336-336, Article 336

2019

Volltextzugriff (PDF)

Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial

JMIR research protocols, 2023-10, Vol.12, p.e48386-e48386

2023

Volltextzugriff (PDF)

Adult Wilms tumour: A case report

SAGE open medical case reports, 2022, Vol.10, p.2050313X221097265

2022

Volltextzugriff (PDF)

A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial

PloS one, 2024-06, Vol.19 (6), p.e0304573

2024

Volltextzugriff (PDF)

Humoral and cellular immune response to Sars-CoV-2 wild-type and variants of concern following 3-dose vaccination in a large cohort of adults with cancer: The SerOzNET study

Journal of clinical oncology, 2022-06, Vol.40 (17_suppl), p.LBA12065-LBA12065

2022

Volltextzugriff (PDF)

Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors

Supportive care in cancer, 2023-08, Vol.31 (8), p.484-484, Article 484

2023

Volltextzugriff (PDF)

Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study

European journal of cancer (1990), 2021-11, Vol.157, p.225-237

2021

Volltextzugriff (PDF)

Adverse events and estimated costs with the combination of ipilimumab and nivolumab in metastatic melanoma patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21529-e21529

2021

Volltextzugriff (PDF)

The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study

Journal of neuro-oncology, 2020, Vol.146 (1), p.181-193

2020

Volltextzugriff (PDF)

Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma

Cancers, 2022-02, Vol.14 (5), p.1162

2022

Volltextzugriff (PDF)

Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study

Cancers, 2023-01, Vol.15 (1), p.316

2023

Volltextzugriff (PDF)

Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma

Cancers, 2022-12, Vol.15 (1), p.31

2022

Volltextzugriff (PDF)

Neoadjuvant Immunotherapy in Melanoma: The Paradigm Shift

American Society of Clinical Oncology educational book, 2023-01, Vol.43 (43), p.e390614-e390614

2023

Volltextzugriff (PDF)

The sleep, cancer and rest (SleepCaRe) trial: Rationale and design of a randomized, controlled trial of cognitive behavioral and bright light therapy for insomnia and fatigue in women with breast cancer receiving chemotherapy

Contemporary clinical trials, 2022-09, Vol.120, p.106877-106877, Article 106877

2022

Volltextzugriff (PDF)

Advances in Oncology 2019

Revue médicale suisse, 2020-01, Vol.16 (676-7), p.72

2020

Volltextzugriff (PDF)

Oncologie

Revue médicale suisse, 2020, Vol.16 (676-77), p.72-77

2020

Volltextzugriff (PDF)

Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstract

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT259-CT259

2022

Volltextzugriff (PDF)

Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNET

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT567-CT567

2022

Volltextzugriff (PDF)

BRCA mutations: from Angelina Jolie to specific therapies

Revue médicale suisse, 2016-05, Vol.12 (519), p.973

2016

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(27)
Berichte
(1)

Sprache

Englisch
(26)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunotherapy-Induced Airway Disease: A New Pattern of Lung Toxicity of Immune Checkpoint Inhibitors

Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma

Gender profile of principal investigators in a large academic clinical trials group

Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48Leu- and FGFR4 p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized Oncology

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient

Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial

Adult Wilms tumour: A case report

Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data

A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial

Humoral and cellular immune response to Sars-CoV-2 wild-type and variants of concern following 3-dose vaccination in a large cohort of adults with cancer: The SerOzNET study

Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors

Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study

Adverse events and estimated costs with the combination of ipilimumab and nivolumab in metastatic melanoma patients

The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study

Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma

Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study

Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma

Neoadjuvant Immunotherapy in Melanoma: The Paradigm Shift

The sleep, cancer and rest (SleepCaRe) trial: Rationale and design of a randomized, controlled trial of cognitive behavioral and bright light therapy for insomnia and fatigue in women with breast cancer receiving chemotherapy

Advances in Oncology 2019

Oncologie

Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstract

Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNET

BRCA mutations: from Angelina Jolie to specific therapies

Suchergebnisse filtern